SNUBI Research ::   (155 talks satisfying Presenter = )
All  Seminar  BioEMR  xMutant  SysBiol  MAInfo  J.Club  TopicSem  BookReading    This week    Help

ADD NEW USER

:   ǥ:    /Ű:    ¥:   

2022-02:
03 TopicSem
12 J.Club
28 TopicSem

2021-12:
06 Ampliseq custome panel for analyze drug response and sequencing results of NUDT15 and TPMT gene  TopicSem
18 High antibiotic resistance of Helicobacter pylori and its associated novel gene mutations among the mongolian population     J.Club
30   TopicSem

2021-11:
04 Ampliseq panel for variants associated with antibiotics resistance in H.pylori  TopicSem

2021-10:
07 NGS platform for Helicobacter pylori ampliseq panel  TopicSem
23 Position effects at the FGF8 locus are associated with femoral hypoplasia     J.Club

2021-09:
02 Comparison with AML H. pylori antibiotic resistance NGS panel  TopicSem
02 Comparison with AML H. pylori antibiotic resistance NGS panel  TopicSem

2021-08:
14 Comparison of culture with antibiogram to NGS using bacterial isolates and formalin fixed paraffin embedded gastric biopsies     J.Club

2021-07:
29 Scale down the target ampliseq panel of host whole exome plus H.pylori genes for clinical application  TopicSem

2021-06:
12 High-throughput reclassification of SCN5A variant     J.Club
21 Comparison of Helicobacter pylori ampliseq panel and DPO-PCR method   TopicSem

2021-05:
06 Individual antibiotics resistance profiles for antibiotics used in H.pylori therapy  TopicSem

2021-04:
05 Helicobacter pylori panel validation result  TopicSem
17 Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance     J.Club

2021-03:
11 Deleterious variants identified in normal cohort and its metabolic enzyme activity distance from normal function CYP2C19  TopicSem
23 PGx of Host and Pathogen in Helicobacter Pylori Infection  Seminar

2021-02:
15 Metabolic activity of mutant CYP2C19 with two types of substrates  TopicSem
27 De novo and bi-allelic pathogenic variants in NARS1 cause neurodevelopmental delay due to toxic gain-of-function and partial loss-of-function effects     J.Club

2021-01:
02 Genomic sequencing for newborn screening: results of the NC NEXUS project     J.Club
07 Variants associated with antibiotics in 23S ribosomal RNA gene of H.pylori  TopicSem
25 Known mutations in ribosomal binding site of rRNA genes of H.pylori  TopicSem

2020-12:
17 Sequencing result of NUDT15 and TPMT gene in 150 leukemia patients by using next-generation sequencing panel  TopicSem

2020-11:
02 Measuring enzyme activity of mutant CYP2C19 by using mephenytoin  TopicSem
21 Germline and mosaic variants in PRKACA and PRKACB cause a multiple congenital malformation syndrome     J.Club
26 Enzymatic activity of mutant CYP2C19 and variant impact prediction scores  TopicSem

2020-10:
08 Mutant CYP2C19 overexpression by using human cell system  TopicSem

2020-09:
07 Known mutations in H.pylori genome associated with Amoxicillin resistance and Metronidazole resistance phenotype  TopicSem
26 Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes     J.Club

2020-08:
01 De novo variants in SPOP cause two clinically distinct neurodevelopmental disorders     J.Club
20 CYP2C19 star allele for PPI treatment in Helicobacter pylori eradication therapy  TopicSem

2020-07:
16 Mutations associated with Tetracycline and Levofloxacin resistance phenotype in H.pylori  TopicSem

2020-06:
15 Variants in H.pylori associated with Clarithromycin resistance phenotype  TopicSem

2020-05:
18 F10 amino acid changes identified from symptomatic subjects of Factor X deficiency  TopicSem
30 SYCP2 translocation-mediated dysregulation and frameshift variants cause human male infertility     J.Club

2020-04:
04 Opposite modulation of RAC1 by mutations in TRIO is associated with distinct, domain-specific neurodevelopmental disorders     J.Club
20 FX activity evaluation by using recombinant FX mutant protein  TopicSem

2020-03:
23 Chromogenic activity evaluation of FX protein with mutant catalytic domain  TopicSem

2020-02:
24 Chromogenic activity of overexpressed F10 protein with mutant catalytic domain  TopicSem

2020-01:
09 Application of next‑generation sequencing to analyze drug response in human leukemia by using the panel including 11 genes  TopicSem
18 Gain-of-function MN1 truncation variants cause a recognizable syndrome with craniofacial and brain abnormalities     J.Club

2019-12:
05 Antibiotics resistance variants in Helicobacter pylori sequence identified from H.plyori panel sequencing  TopicSem

2019-11:
04 Target sequencing panel for Helicobacter pylori and host DNA  TopicSem
16 Diagnostic utility of Next-Generation Sequencing for Disorders of Somatic Mosaicism-a five-year cumulative cohort     J.Club

2019-09:
23 Deleterious variants in CYP2C19 Rapid metabolizer  TopicSem

2019-08:
05 Comparison between full matrix and sparse matrix in CYP2C19 gene  TopicSem
24 Paralog studies augment gene discovery:DDX and DHX genes     J.Club

2019-07:
04 Systematic mutagenesis and enzymatic activity assay for CYP2C19 gene  TopicSem

2019-06:
22 Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington Disease     J.Club

2019-05:
27 Work flow for systematic mutagenesis candidate selection  TopicSem

2019-04:
06 Variants of unknown significance in genes associated with heritable thoracic aortic disease can be low penetrant risk variants     J.Club
18 Candidate variants in 12 genes for systematic mutagenesis  TopicSem

2019-03:
11 Candidate variant selection for systematic mutagenesis and suitable activity assay  TopicSem

2019-02:
02 The malaria-protective human glycophorin structural variant DUP4 shows somatic mosaicism and association with hemoglobin levels     J.Club

2019-01:
24 Protein domain structure and star alleles of candidate proteins for mutagenesis  TopicSem

2018-12:
01 Homozygous mutations in WEE2 cause fertilization failure and female infertility      J.Club
24 Protein domain structure of activity assay candidate proteins  TopicSem

2018-11:
22 Chromogenic activity evaluation in catalytic domain of FX  TopicSem

2018-10:
22 Chromogenic activity of FX protein with variants and related protein structure  TopicSem

2018-09:
10 Measuring activity of chromogenic FX protein with target variant  TopicSem
29 A dominantly inherited 5` UTR variant causing methylation-associated silencing of BRCA1 as a cause of breast and ovarian cancer      J.Club

2018-08:
06 Overexpression of FX protein with target variant  TopicSem

2018-07:
05 DNA transfection to 293 cell line for overexpression of FX with the variants  TopicSem
28 Functional assays are essential for interpretation of missense variants associated with variable expressivity     J.Club

2018-06:
11 1000 genome variants in CYP2C19 gene  TopicSem

2018-05:
19 Antisense therapy for a common corneal dystrophy ameliorates TCF4 repeat expansion-mediated toxicity     J.Club

2018-04:
30 Mutagenesis and transformation for FX chromogenic activity assay  TopicSem

2018-03:
03 Disease model discovery from 3,328 gene knockouts by The International Mouse Phenotyping Consortium     J.Club
26 Additional variant selection for FX chromogenic activity assay  TopicSem

2018-02:
05 Site-direct mutagenesis for FX protein activity assay  TopicSem

2018-01:
08 Reinforcement for low coverage regions in DRP290 SNP Panel and LT Ampliseq WES  TopicSem

2017-12:
04 Experimental modification of Exome + DRP290 SNP Panel and 2nd test result  TopicSem
23 PGBD5 promotes site-specific oncogenic mutations in human tumors     J.Club

2017-11:
01 Design of Exome + DRP290 SNP Panel and experimental modification  TopicSem

2017-10:
21 Loss-of-function and gain-of-function mutations in KCNQ5 cause intellectual disability or epileptic encephalopathy     J.Club

2017-09:
20 Whole size FX cDNA library synthesis for cloning and activity assay data analysis plan  TopicSem

2017-08:
12 Evaluating the clinical validity of gene-disease associations an evidence-based framework developed by the clinical genome resource     J.Club
14 Synthesis cDNA library of FX gene from lymphoblast cell line  TopicSem

2017-07:
12 Preparing cDNA library of FX gene by using lymphoblast cell lines  TopicSem

2017-06:
12 FX cDNA library preparation by using lymphoblast cell lines  TopicSem

2017-05:
01 Treatment of lymphoblastoid cell line containing FX variants  TopicSem
27 A common variant at the 14q32 endometrial cancer risk locus activates AKT1 through YY1 binding     J.Club

2017-03:
11 Mutations in three genes encoding proteins involved in hair shaft formation cause uncombable hair syndrome     J.Club
29 Validation for candidate genes in familial-NMTC cases  TopicSem

2017-02:
08 Comparison of manual and semi-automatic NGS result  TopicSem

2016-12:
17 Sequencing the GRHL3 coding region reveals rare truncating mutations and a common susceptibility variant for nonsyndromic cleft palate     J.Club
28 FNMTC candidate gene shared between two ns-FNMTC families  TopicSem

2016-11:
28 FNMTC candidate gene validation using Sanger sequencing and THCA data  TopicSem

2016-10:
12 Experimental validation for candidate variants of FNMTC family  TopicSem

2016-09:
24 Parent-of-origin-specific signatures of de novo mutations     J.Club

2016-08:
31 Validation of candidate variants for the FNMTC family  TopicSem

2016-07:
16 Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma     J.Club
18 WES analysis to detect shared causal genes in FNMTC families  TopicSem

2016-06:
13 Rare indel variant analysis in WES data of FNMTC family  TopicSem

2016-05:
04 Rare variant analysis in FNMTC by sequencing 3 affected individuals and 2 unaffected family members  TopicSem

2016-04:
30 De novo loss-of-function mutations in USP9X cause a female-specific recognizable syndrome with developmental delay and congenital malformations     J.Club

2016-03:
30 Rare variant analysis in non-syndromic FNMTC families by using WES  TopicSem

2016-02:
17 WES analysis of non-syndromic FNMTC by sequencing 3 affected individuals and an unaffected family member  TopicSem
27 Mutations in the transcriptional repressor REST predispose to Wilms tumor     J.Club

2016-01:
13 Comparison of customized cancer core panel with ion cancer hotspot panel  TopicSem

2015-12:
09 Target sequencing by using cancer core panel for target therapies  TopicSem
12 Germline heterozygous variants in SEC23B are associated with Cowden Syndrome and enriched in apparently sporadic thyroid cancer     J.Club

2015-11:
04 Variant filtration to detect causal gene of non-syndromic FNMTC  TopicSem

2015-09:
19 Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer     J.Club
23 WES analysis of non-syndromic FNMTC in two families  TopicSem

2015-08:
10 Causal gene identification of non-syndromic FNMTC by using WES data  TopicSem

2015-07:
06 Genome analysis of non-syndromic Familial NMTC  TopicSem

2015-06:
03 Exome sequencing to detect inherited causes of FNMTC  TopicSem
27 Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome     J.Club

2015-04:
18 A recurrent mutation in PARK2 is associated with familial lung cancer     J.Club
29 Identification of inherited causes of FNMTC  TopicSem

2015-03:
30 Study plan for to detect causal variants in FNMTC  TopicSem

2015-02:
16 Finding causal variants in Familial non medullary thyroid cancer (FNMTC)  TopicSem

2015-01:
31 TBX6 Null Variants and a Common Hypomorphic Allele in Congenital Scoliosis     J.Club

2014-12:
06 Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease     J.Club
24 Comparison of cancer panel designs based on two major capture methods  TopicSem

2014-11:
19 WES to detect abnormalities causing Yutopar side effects in pregnant women  TopicSem

2014-10:
13 NGS panel for Busulfan, COPD, 6MP, ADME Core and pharmacogenomic variants  TopicSem

2014-09:
13 A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia     J.Club

2014-08:
20 Modified targeted cancer panel  TopicSem

2014-07:
19 Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation     J.Club
23 Design targeted cancer panel using ampliseq method  TopicSem

2014-06:
25 Targeted cancer panel to analysis multiple types of mutation  TopicSem

2014-05:
10 Loss-of-function mutations in SLC30A8 protect against type 2 diabetes     J.Club
26 Experimental modification of Ampliseq sequencing  TopicSem

2014-04:
21 DNA quality and NGS library preparation  TopicSem

2014-03:
03 Whole exome sequencing by using Ion Proton  TopicSem
22 Using Whole-Exome Sequencing to Identify Inherited Causes of Autism     J.Club
31 Whole exome sequencing by using Ampliseq system  TopicSem

2014-02:
03 Targeted sequencing system  TopicSem

2014-01:
08 Targeted sequencing using the target enrichment system  TopicSem

2013-12:
11 PD-AMSCs RNA sequencing  TopicSem
24 Experimental methods for RNA sequencing  SysBiol
28 Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes     J.Club

2013-11:
02 A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion     J.Club
06 rRNA Depletion and library prep for RNA sequencing  TopicSem

2013-10:
15 Finding the lost factors in exome sequencing data  SysBiol
16 RNA sequencing by using Ion Proton   TopicSem

2013-09:
11 Ion Proton training sequencing  TopicSem
14 Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss     J.Club

2013-08:
03 Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas     J.Club
06 Analysis of epigenetic modification by bisulfite conversion  SysBiol
07 Genotyping using multiplexing fragment analysis method  TopicSem

2013-07:
27 CpG island analysis for personal genome interpretation  SysBiol
29 CpG island analysis for MALT lymphoma  TopicSem

2013-06:
04 Personal genome related DB review(4) - GWASdb  SysBiol
08 Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration     J.Club
24 Chromosomal rearrangement analysis of bone abnormality with CNP overexpression  TopicSem

2013-05:
08 Genomic analysis of Retinitis Pigmentosa by using targeted exome capture sequencing  TopicSem
29 Chromosomal rearrangement analysis of bone abnormality with CNP overexpression  TopicSem

2013-04:
13 Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA      J.Club
27 case report of Target sequencing and its validation in 22 family  SysBiol

powered by SNUBI